Menopause
Conference Coverage
CBT for insomnia and hot flashes lifts mood in midlife
PHILADELPHIA – The intervention was effective even for women with the highest depression scores.
Conference Coverage
Oral bioidentical combo improves quality of life, vasomotor symptoms
PHILADELPHIA – If approved, the new formulation could offer an option for women currently using compounded bioidenticals.
Conference Coverage
Time to take the fear out of the hormone therapy conversation
PHILADELPHIA – The executive director of the North American Menopause Society says the new message is to use appropriate hormone therapy to meet...
Conference Coverage
Gap in osteoporosis diagnosis and treatment stirs concern
A decline in the diagnosis and treatment of osteoporosis has experts worried about a new epidemic of fractures. Fracture liaison services and...
From the Journals
WHI hormone trials offer reassurance on long-term mortality risk
New data from the WHI trials suggest that the use of conjugated equine estrogens alone or with medroxyprogesterone acetate is safe for 5-7 years...
News from the FDA/CDC
Sleep issues vary by menopausal status
Report examines sleep duration and quality in women aged 40-59 years.
Conference Coverage
Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosis
An analysis of a 7-year, open-label extension study of denosumab in women found a 0.05% overall rate of jaw osteonecrosis and a 0.7% rate...
From the Journals
Focus on lifestyle to manage menopause symptoms after breast cancer
Smoking cessation, weight loss and exercise, limiting alcohol intake, maintenance of adequate vitamin D and calcium levels, and a healthy diet...
Conference Coverage
Anabolic agents for osteoporosis have limited role so far
Parathyroid hormone and parathyroid hormone-related protein analogs show promise for osteoporosis, but, for now, they’re reserved for the most...
Conference Coverage
Romosozumab cuts new vertebral fracture risk by 73%, but safety data are concerning
MADRID – Investigational bone-building drug looks promising, but safety concerns emerge.
Conference Coverage
Endometriosis after menopause: Weigh the treatment risks
VANCOUVER – Age and previous disease severity are important factors in weighing whether to prescribe hormone therapy for postmenopausal women with...